26 April 2019 : Original article
Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
DOI: 10.12659/MSM.914860
Med Sci Monit 2019; 25:3069-3076
HTML version available soon